Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7262643 | Behaviour Research and Therapy | 2014 | 44 Pages |
Abstract
We conducted a 4-year follow-up study of participants who had received ICBT or CBGT for SAD within the context of a randomized controlled non-inferiority trial. The cost-effectiveness analyses were conducted taking a societal perspective. Participants in both treatment groups made large improvements from baseline to 4-year follow-up on the primary outcome measure (d = 1.34-1.48) and the 95% CI of the mean difference on the primary outcome was well within the non-inferiority margin. ICBT and CBGT were similarly cost-effective and both groups reduced their indirect costs. We conclude that ICBT for SAD yields large sustainable effects and is at least as long-term effective as CBGT. Intervention costs of both treatments are offset by net societal cost reductions in a short time.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Erik Hedman, Samir El Alaoui, Nils Lindefors, Erik Andersson, Christian Rück, Ata Ghaderi, Viktor Kaldo, Mats Lekander, Gerhard Andersson, Brjánn Ljótsson,